coronaviru
diseas
show
wide
variat
express
sever
symptom
mild
symptom
flulik
symptom
sever
case
pneumonia
acut
respiratori
distress
syndrom
even
death
larg
differ
outcom
also
observ
male
femal
caus
variabl
like
multifactori
includ
genet
viru
respons
infect
use
human
receptor
angiotensin
convert
enzym
cell
invas
serin
proteas
protein
prime
genet
variat
two
gene
may
thu
modul
individu
genet
predisposit
infect
viru
clearanc
genet
data
patient
gather
carri
phenomewid
associ
scan
phewa
investig
role
gene
human
phenotyp
gener
popul
examin
quantit
phenotyp
includ
cytokin
cardiometabol
biomark
well
medic
volunt
lifelin
popul
biobank
relat
genet
variant
locat
near
none
reach
threshold
signific
observ
suggest
associ
polymorph
within
gene
use
angiotensin
ii
receptor
blocker
arb
combin
therapi
associ
significantli
stronger
femal
p
diff
use
nonsteroid
antiinflammatori
antirheumat
product
associ
need
confirm
larger
sampl
size
suggest
variant
play
role
diseas
hypertens
chronic
inflamm
often
observ
sever
case
recent
outbreak
coronaviru
diseas
caus
viru
quickli
becom
pandem
pose
great
threat
public
health
wide
rang
clinic
manifest
infect
peopl
asymptomat
symptomat
mild
respiratori
symptom
sever
pneumonia
wu
mcgoogan
huang
et
al
xu
et
al
estim
base
report
case
februari
china
indic
approxim
patient
develop
sever
respiratori
ill
requir
hospit
overal
mortal
estim
around
wu
mcgoogan
estim
fix
becom
precis
case
report
screen
analyz
interestingli
high
variabl
estim
compar
countri
contin
well
differ
sever
male
femal
differ
age
group
wu
mcgoogan
chen
et
al
situat
report
march
differ
respons
infect
individu
countri
may
explain
diminish
immun
respons
elderli
comorbid
smoke
habit
guan
et
al
sever
case
also
observ
young
individu
seemingli
without
risk
factor
indic
factor
explain
sever
still
unknown
therefor
critic
understand
mechan
behind
sever
order
provid
appropri
prevent
measur
adequ
triag
strategi
guid
drug
discoveri
process
ultim
combat
pandem
larg
variat
infect
rate
sever
could
potenti
explain
genet
differ
host
largescal
genet
studi
patient
assembl
coordin
covid
host
genet
consortium
http
worthwhil
evalu
effect
genet
variant
gene
involv
infect
human
phenotyp
includ
quantit
trait
take
advantag
alreadi
exist
cohort
fact
quantit
phenotyp
alway
directli
associ
diseas
knowledg
genet
variant
modul
trait
improv
understand
diseas
onset
variabl
symptom
one
exampl
work
genet
variant
gene
associ
genomewid
associ
studi
gwa
fetal
hemoglobin
hbf
product
gener
popul
menzel
et
al
genet
variant
subsequ
found
modul
sever
betathalassemia
sickl
cell
diseas
lettr
et
al
observ
explain
certain
individu
natur
predispos
mild
symptom
diseas
other
sever
clinic
outcom
benefit
hbf
increas
drug
therefor
understand
role
genet
variant
gene
essenti
infect
human
quantit
phenotyp
import
explain
observ
variabl
infect
suscept
sever
understand
may
suggest
potenti
treatment
factor
necessari
infect
known
hoffmann
et
al
yan
et
al
angiotensin
convert
enzym
necessari
invas
viru
host
cell
viral
spike
protein
transmembran
serin
proteas
necessari
correct
matur
viral
spike
protein
enter
cell
yan
et
al
accord
gwa
catalogu
see
url
genet
variant
near
locat
chromosom
associ
suscept
prostat
cancer
mortal
rate
popul
associ
report
variant
near
partli
explain
fact
gene
locat
x
chromosom
part
genom
often
analys
larg
scale
genom
wide
associ
studi
gwa
due
differ
analysi
workflow
autosom
chromosom
potenti
associ
human
phenotyp
near
could
therefor
miss
investig
associ
genet
variant
within
near
transcript
phenomewid
associ
scan
phewa
volunt
lifelin
popul
cohort
analys
quantit
phenotyp
use
differ
drug
categori
entir
cohort
protein
level
plasma
cytokin
subset
individu
quantit
phenotyp
select
anthropometr
trait
measur
paramet
lung
hearth
kidney
haematolog
immun
cardiometabol
function
final
evalu
whether
variant
differ
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
associ
male
femal
explor
potenti
gender
differ
could
modul
infect
lifelin
cohort
scholten
et
al
multidisciplinari
prospect
populationbas
cohort
studi
uniqu
three
gener
design
examin
health
healthrel
behaviour
individu
live
north
netherland
approv
medic
ethic
committe
univers
medic
center
groningen
conduct
accord
helsinki
declar
guidelin
particip
sign
inform
consent
form
prior
enrol
lifelin
employ
broad
rang
investig
procedur
assess
impact
biomed
sociodemograph
behaviour
physic
psycholog
factor
multimorbid
complex
genet
subset
volunt
genotyp
use
infinium
global
screen
gsa
multiethn
diseas
version
accord
manufactur
instruct
rotterdam
genotyp
center
depart
genet
univers
medic
center
groningen
perform
standard
qualiti
control
sampl
marker
includ
remov
sampl
variant
low
genotyp
call
rate
variant
show
deviat
hardyweinberg
equilibrium
p
excess
mendelian
error
famili
parentoffspr
pair
sampl
high
low
heterozygos
check
remov
sampl
show
consist
sex
inform
compar
genotyp
x
chromosom
report
famili
inform
observ
identitybydesc
share
famili
member
genotyp
avail
previou
studi
tigchelaar
et
al
francioli
et
al
detail
descript
process
found
follow
link
http
van
der
veld
et
al
qualiti
check
total
sampl
autosom
xchromosom
marker
avail
analysi
genotyp
dataset
imput
use
haplotyp
refer
consortium
hrc
panel
sanger
imput
server
see
url
consortium
variant
imput
qualiti
score
higher
variant
maf
higher
rare
variant
maf
retain
individu
whose
genotyp
pass
qualiti
control
femal
averag
age
phenotyp
collect
year
year
quantit
phenotyp
measur
previous
describ
scholten
et
al
tabl
protein
level
plasma
cardiovascularrel
protein
determin
use
olink
proseek
multiplex
cvd
iii
panel
olink
uppsala
sweden
concentr
plasma
citrullin
cytokin
measur
procartaplex
tm
multiplex
immunoassay
ebiosci
usa
describ
previous
zhernakova
et
al
zhernakova
et
al
zhernakova
et
al
medic
use
record
base
drug
packag
brought
particip
first
visit
lifelin
inclus
center
registr
medic
use
way
shown
fairli
highli
concord
health
record
inform
sediq
et
al
convers
anatom
therapeut
chemic
classif
atc
code
first
four
letter
level
use
defin
drug
categori
associ
analys
atc
code
less
observ
consid
analysi
leav
drug
categori
analysi
supplementari
tabl
test
quantit
phenotyp
use
linearmix
model
implement
saigegd
correct
famili
relationship
cryptic
popul
structur
zhou
et
al
zheng
et
al
x
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
chromosom
genotyp
male
consid
diploid
test
genet
variant
within
near
transcript
singlenucleotid
polymorph
snp
insert
delet
minor
allel
frequenc
maf
genotyp
imput
pass
qualiti
control
describ
analysi
saigegd
carri
quantit
phenotyp
avail
subset
sampl
tabl
drug
categori
analys
binari
trait
medic
current
use
otherwis
restrict
genet
variant
maf
analys
age
sex
use
covari
inversenorm
transform
appli
quantit
trait
prior
model
fit
evalu
genderspecif
effect
analyz
male
femal
separ
use
age
covari
transform
use
analysi
entir
cohort
circul
plasma
protein
cytokin
measur
small
subset
unrel
individu
thu
requir
correct
famili
relationship
analys
use
plink
perform
associ
map
sex
jointli
separ
describ
use
inversenorm
transform
trait
analyz
variant
trait
combin
without
inclus
age
sex
covari
genet
variant
combin
low
sampl
size
highli
correl
covari
make
estim
imposs
use
linearmix
model
analyz
common
low
frequenc
minor
allel
frequenc
maf
genet
variant
near
transcript
associ
quantit
trait
supplementari
tabl
none
found
signific
standard
genomewid
level
benjaminhochberg
fals
discoveri
rate
fdr
signific
associ
found
quantit
trait
locu
triglycerid
eosinophil
count
strongest
associ
locu
plasma
level
thrombocyt
tabl
associ
triglycerid
show
differenti
effect
male
femal
cochran
q
test
p
diff
signal
observ
combin
analysi
signal
attribut
male
although
associ
remain
suggest
find
signal
restrict
either
male
femal
p
associ
genderspecif
analys
look
result
obtain
eosinophil
triglycerid
thrombocyt
least
sampl
ukbiobank
see
url
none
associ
report
tabl
found
signific
p
analysi
focus
variant
minor
allel
frequenc
maf
quantit
phenotyp
none
genet
variant
show
genomewid
signific
associ
medic
use
supplementari
tabl
strongest
associ
locu
observ
group
drug
contain
nonsteroid
antiinflammatori
antirheumat
product
nsaid
odd
ratio
g
allel
tabl
group
contain
angiotensin
ii
receptor
blocker
arb
combin
antihypertens
drug
allel
tabl
nsaid
use
treat
pain
fever
inflamm
includ
ibuprofen
signific
stronger
male
femal
effect
size
statist
differ
p
diff
second
group
drug
encod
combin
therapi
use
treat
hypertens
combin
therapi
arb
hypertens
drug
usual
initi
second
option
antihypertens
effect
arb
alon
suffici
flack
ram
result
indic
individu
carri
least
one
allel
polymorph
like
take
combin
therapi
compar
individu
allel
effect
snp
also
signific
consid
arb
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
intak
thu
associ
arb
combin
therapi
could
indic
individu
difficult
manag
hypertens
may
genet
predispos
state
interestingli
analys
male
femal
separ
found
effect
arb
combin
therapi
femalespecif
even
account
differ
number
user
femal
vs
male
p
diff
howev
none
associ
meet
either
genomewid
fdr
threshold
signific
larger
sampl
size
necessari
confirm
observ
strongest
associ
locu
observ
group
drug
contain
antimycot
prescript
corticosteroid
signific
differ
sex
observ
two
associ
p
diff
attempt
valid
find
medic
use
use
ukbiobank
public
gwa
summari
statist
see
url
although
data
refer
use
individu
medic
rather
drug
categori
consid
medic
categori
commonli
use
user
cohort
found
nomin
associ
direct
effect
glucosamin
use
combin
analysi
male
candersartancilexetil
femal
supplementari
tabl
lack
replic
could
attribut
differ
medic
usag
report
studi
base
selfreport
inform
lifelin
studi
record
confirm
medic
packag
collect
nurs
recruit
recent
studi
demonstr
use
key
receptor
invad
cell
yan
et
al
cell
invas
enhanc
express
hoffmann
et
al
genet
variat
two
gene
interfer
gene
function
may
thu
involv
observ
variabl
suscept
sever
associ
genet
variant
human
phenotyp
gener
popul
may
suggest
potenti
treatment
help
better
identifi
atrisk
individu
use
cohort
individu
lifelin
gener
popul
cohort
investig
impact
variant
near
within
two
gene
quantit
trait
includ
measur
paramet
lung
hearth
kidney
hematolog
immun
cardiometabol
function
found
signific
evid
common
low
frequenc
variant
loci
associ
measur
quantit
trait
gener
popul
observ
suggest
signal
phenotyp
triglycerid
thrombocyt
involv
cardiovascular
diseas
consid
risk
factor
diseas
wu
mcgoogan
none
genet
variant
reach
statist
signific
despit
larg
sampl
size
nevertheless
exclud
role
variant
regul
sever
relev
phenotyp
specif
immun
cell
type
cytokin
level
measur
cohort
evalu
effect
genet
variat
clinic
relev
phenotyp
investig
associ
genet
medic
use
observ
margin
associ
variant
near
use
arb
combin
therapi
use
nonsteroid
antiinflammatori
antirheumat
drug
nsaid
interestingli
margin
associ
arb
categori
also
observ
locu
result
intrigu
consid
current
debat
whether
use
arb
nsaid
could
worsen
sever
russel
et
al
littl
kuster
et
al
potenti
effect
increas
express
signific
associ
found
variant
blood
pressur
measur
inflammatori
marker
cohort
p
even
use
drug
ad
covari
data
shown
associ
diastol
systol
blood
pressur
also
observ
larg
ukbiobank
dataset
thu
variant
like
associ
clinic
condit
hypertens
chronic
inflamm
better
drug
respons
arb
prefer
altern
patient
experi
aceinhibitor
induc
cough
howev
associ
advers
drug
reaction
adr
result
like
independ
switch
arb
due
aceinhibitor
induc
cough
ma
et
al
interestingli
associ
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
snp
arb
specif
arb
combin
therapi
thu
point
individu
difficulttomanag
hypertens
major
allel
differ
frequenc
across
popul
european
east
asian
south
asian
accord
genom
see
url
likewis
g
allel
snp
associ
higher
probabl
nsaid
use
show
substanti
differ
frequenc
among
popul
mostli
absent
asian
european
european
east
asian
south
asian
accord
genom
see
url
preferenti
use
nsaid
arb
combin
therapi
differ
genotyp
frequenc
popul
genderspecif
effect
could
partial
explain
observ
variat
sever
unfortun
studi
prove
genet
associ
directli
relat
suscept
sever
arb
nsaid
improv
worsen
suscept
sever
studi
follow
limit
first
age
sex
use
covari
analys
may
suffici
correct
confound
trait
drug
usag
diseas
although
effect
confound
mitig
larg
sampl
size
secondli
analys
medic
use
underpow
given
limit
number
individu
gener
popul
use
medic
test
thu
none
associ
found
met
multipletest
adjust
signific
third
result
medic
use
includ
low
frequenc
none
analysi
includ
rare
variant
maf
could
still
relev
fourth
specul
potenti
connect
result
current
knowledg
longitudin
wellcharacter
data
patient
need
explor
hypothesi
conclus
carri
extens
screen
potenti
genet
associ
common
low
frequenc
variant
gene
found
lack
substanti
effect
human
quantit
phenotyp
variat
gener
popul
genet
analys
phenotyp
need
evalu
function
role
physiolog
process
final
sinc
genet
variat
gene
exampl
involv
regul
immun
system
could
also
import
determin
suscept
diseas
sever
larg
scale
genet
initi
like
host
genet
consortium
http
directli
involv
patient
deepli
character
genom
phenotyp
urgent
need
raul
aguirregamboa
patrick
deelen
lude
frank
jan
kuivenhoven
data
avail
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
data
analys
studi
obtain
lifelin
biobank
project
applic
number
request
access
dataset
direct
lifelin
research
offic
research
lifelinesnl
full
summari
statist
result
avail
http
